Enzyme-linked immunosorbent assay (ELISA) testing Market - Global Industry Analysis

Market Overview

The global Enzyme-linked immunosorbent assay (ELISA) testing market accounted for USD 513.4 Million in 2020 and is expected to reach USD 725.6 Million by 2028, growing at a CAGR of around 4.4 % between 2021 and 2028. 

The global Enzyme-linked immunosorbent assay (ELISA) Market is a test that detects and/or quantifies antibodies in biological samples. This test can be used to determine if the sample has antibodies related to or generated against a specific antigen related to a certain infectious condition. Antibodies are proteins that are produced against foreign pathogens as an immunogenic response to harmful substances called pathogens. ELISA is a biochemical reaction in which an antigen is adsorbed on a solid surface. An antibody linked to an enzyme is allowed with the antigen and is detected by adding a substrate specific to the linked enzyme. ELISA test plays very important role in the diagnosis of viral infections such as HIV, varicella-zoster virus, which causes chickenpox and shingles, rotavirus, Zika virus, syphilis etc. ELISA is often used as a screening tool before more in-depth tests are carried out. ELISA also can be used in pharmaceutical quality control tests such as endotoxin tests, protein quantification.    

COVID-19 Impact Analysis:

The restrictions imposed by various nations to contain COVID had stopped the demand and supply resulting in disruption across the whole supply chain. However, the global markets are slowly opening to their full potential, and theirs a surge in demand. The market would remain bullish in the upcoming year.  The significant decrease in the global Enzyme-linked immunosorbent assay (ELISA) testing market size in 2020 is estimated on the basis of the COVID-19 outbreak and its negative impact on the economies and industries across the globe. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.

To know more about this report, request a sample copy.

Growth Factors

The global Enzyme-Linked Immunosorbent Assay (ELISA) testing market is primarily driven by the emergence of cost-effective technologies and laboratory automation for ELISA assay. Other major driving factors are increasing research and development on biomarkers and monoclonal antibodies (mABs) coupled with continued growth in the drug discovery market. However, the threat of substitution by new technologies such as multiplex proteomic array platforms is the major restraint that may limit the growth of the market. Nonetheless increasing the need for accurate and early disease diagnosis owing to the increasing burden of chronic diseases across the globe along with the increasing geriatric population base are likely to disclose new avenues for the Enzyme-Linked Immunosorbent Assay (ELISA) testing market in the near future.

Report Scope:  

Segment Analysis Preview  

The Enzyme-Linked Immunosorbent Assay (ELISA) testing market is segmented on the basis of different test types such as Test type, indirect ELISA, multiple and portable ELISA, and competitive ELISA. The indirect ELISA segment is expected to grow at the fastest rate in the global market over the forecast period.

Immunology, inflammation, infectious diseases, cancer, protein quantification, and others are the key applications of the global ELISA testing Market. The immunology segment dominated the market in terms of revenue in 2016.

To know more about this report, Request For Customization.

Key Market Players & Competitive Landscape

The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global air quality control system market Thermo Fisher Scientific. Inc., American Laboratory Products Company (ALPCO), BD Biosciences, Bio-Rad Laboratories, Inc., BioMérieux, Ortho-Clinical Diagnostics, Inc., R & D Systems Inc. and ZEUS Scientific, Inc. among others..

 The global Enzyme-linked immunosorbent assay (ELISA) testing Market is segmented as follows:

By Test type

• Sandwich ELISA
• Indirect ELISA
• Multiple and portable ELISA
• Competitive ELISA

By Applications   

• Immunology
• Inflammation
• Infectious diseases
• Cancer
• Protein quantification
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa